Inflammation, von Willebrand factor, and ADAMTS13

Blood. 2018 Jul 12;132(2):141-147. doi: 10.1182/blood-2018-02-769000. Epub 2018 Jun 4.

Abstract

Increasing evidence indicates that inflammation can cause thrombosis by a von Willebrand factor (VWF)-mediated mechanism that includes endothelial activation, secretion of VWF, assembly of hyperadhesive VWF strings and fibers, cleavage by ADAMTS13, and adhesion and deposition of VWF-platelet thrombi in the vasculature. This mechanism appears to contribute to thrombosis not only in small vessels, but also in large vessels. Inflammation and VWF contribute to atherogenesis and may contribute to arterial and venous thrombosis as well as stroke. Elucidation of the mechanism will hopefully identify new targets and suggest new approaches for prevention and intervention.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • ADAMTS13 Protein / genetics*
  • ADAMTS13 Protein / metabolism*
  • Animals
  • Atherosclerosis / etiology
  • Atherosclerosis / metabolism
  • Blood Platelets / metabolism
  • Gene Expression Regulation
  • Humans
  • Inflammation / etiology*
  • Inflammation / metabolism*
  • Oxidation-Reduction
  • Protein Binding
  • Protein Biosynthesis
  • Proteolysis
  • Transcription, Genetic
  • von Willebrand Factor / genetics*
  • von Willebrand Factor / metabolism*

Substances

  • von Willebrand Factor
  • ADAMTS13 Protein